Review Article
Integrin Signaling as a Cancer Drug Target
Table 2
Transgenic mouse models: FAK.
| Model | Cancer type | Effect on tumor growth | Effect on metastasis | Reference |
| FAKfl/fl; MMTV-Cre; PyMT | Breast cancer | Delayed initiation; decreased growth | Decreased lung metastasis | [117] | FAKfl/fl; MMTV-Cre; PyMT | Breast cancer | Reduced tumor cell proliferation | Blocked progression from hyperplasia to carcinoma; blocked metastasis | [118] | FAKfl/fl; MMTV-Cre; PyMT | Breast cancer | Reduced initiation; reduced proliferation; reduced cancer stem/progenitor cell population | Not studied | [119] | FAKfl/fl; MMTV-Cre; PyMT | Breast cancer | Reduced initiation; reduced proliferation; increased apoptosis | Decreased progression from hyperplasia to carcinoma | [120] | FAKfl/fl; K14-CreERT2; two-stage chemical carcinogenesis protocol | Skin cancer | Reduced initiation; reduced growth; increased apoptosis | Reduced progression from papilloma to squamous cell carcinoma | [121] |
|
|